Efficient gene editing in adult mouse livers via adenoviral delivery of CRISPR/Cas9

被引：82

作者：

Cheng, Ranran ^{[1
,2
]}

Peng, Jin ^{[1
,3
,4
]}

Yan, Yonghong ^{[1
]}

Cao, Peili ^{[1
]}

Wang, Jiewei ^{[1
,5
]}

Qiu, Chen ^{[1
]}

Tang, Lichun ^{[1
]}

Liu, Di ^{[1
]}

Tang, Li ^{[1
]}

Jin, Jianping ^{[6
]}

Huang, Xingxu ^{[7
]}

He, Fuchu ^{[1
,8
]}

Zhang, Pumin ^{[1
,8
,9
]}

机构：

[1] Beijing Inst Radiat Med, Beijing Prote Res Ctr, State Key Lab Prote, Beijing 100850, Peoples R China

[2] Beijing Univ Technol, Coll Life Sci & Bioengn, Beijing 100142, Peoples R China

[3] E China Normal Univ, Inst Biomed Sci, Shanghai 200241, Peoples R China

[4] E China Normal Univ, Sch Life Sci, Shanghai 200241, Peoples R China

[5] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Gastroenterol, Hangzhou 310011, Zhejiang, Peoples R China

[6] Univ Texas Hlth Sci Ctr Houston, Dept Biochem & Mol Biol, Houston, TX 77030 USA

[7] Nanjing Univ, Model Anim Res Ctr, Nanjing 210061, Jiangsu, Peoples R China

[8] Natl Ctr Prot Sci Beijing, Beijing 102206, Peoples R China

[9] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA

来源：

FEBS LETTERS | 2014年 / 588卷 / 21期

基金：

中国国家自然科学基金;

关键词：

CRISPR/Cas9; Gene editing; Liver; Adenoviruses; BINDING-PROTEIN-ALPHA; ONE-STEP GENERATION; CONDITIONAL ALLELES; MICE; HOMEOSTASIS; MUTATIONS; SYSTEMS; CAS9;

D O I：

10.1016/j.febslet.2014.09.008

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

We developed an adenovirus-based CRISPR/Cas9 system for gene editing in vivo. In the liver, we demonstrated that the system could reach the level of tissue-specific gene knockout, resulting in phenotypic changes. Given the wide spectrum of cell types susceptible to adenoviral infection, and the fact that adenoviral genome rarely integrates into its host cell genome, we believe the adenovirus-based CRISPR/Cas9 system will find applications in a variety of experimental settings. (C) 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

引用

页码：3954 / 3958

页数：5

共 50 条

[31] Spatiotemporal control of CRISPR/Cas9 gene editing
Zhuo, Chenya
Zhang, Jiabin
Lee, Jung-Hwan
Jiao, Ju
Cheng, Du
Liu, Li
Kim, Hae-Won
Tao, Yu
Li, Mingqiang
SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2021, 6 (01)
[32] Efficient gene editing in Corynebacterium glutamicum using the CRISPR/Cas9 system
Peng, Feng
Wang, Xinyue
Sun, Yang
Dong, Guibin
Yang, Yankun
Liu, Xiuxia
Bai, Zhonghu
MICROBIAL CELL FACTORIES, 2017, 16
[33] Building a Suite of CRISPR/Cas9 Tools for Efficient Switchgrass Gene Editing
Illa-Berenguer, Eudald
LaFayette, Peter R.
Orr, Gary A.
Parrott, Wayne
IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL, 2019, 55 : S58 - S59
[34] Highly Efficient Genome Editing via CRISPR/Cas9 to Create Clock Gene Knockout Cells
Korge, Sandra
Grudziecki, Astrid
Kramer, Achim
JOURNAL OF BIOLOGICAL RHYTHMS, 2015, 30 (05) : 389 - 395
[35] Highly efficient gene inactivation by adenoviral CRISPR/Cas9 in human primary cells
Voets, Olaf
Tielen, Frans
Elstak, Edo
Benschop, Julian
Grimbergen, Max
Stallen, Jan
Janssen, Richard
van Marle, Andre
Essrich, Christian
PLOS ONE, 2017, 12 (08):
[36] Non-viral delivery of CRISPR–Cas9 complexes for targeted gene editing via a polymer delivery system
Jonathan O’Keeffe Ahern
Irene Lara-Sáez
Dezhong Zhou
Rodolfo Murillas
Jose Bonafont
Ángeles Mencía
Marta García
Darío Manzanares
Jennifer Lynch
Ruth Foley
Qian Xu
A Sigen
Fernando Larcher
Wenxin Wang
Gene Therapy, 2022, 29 : 157 - 170
[37] Baculoviral delivery of CRISPR/Cas9 facilitates efficient genome editing in human cells
Hindriksen, Sanne
Bramer, Arne J.
My Anh Truong
Vromans, Martijn J. M.
Post, Jasmin B.
Verlaan-Klink, Ingrid
Snippert, Hugo J.
Lens, Susanne M. A.
Hadders, Michael A.
PLOS ONE, 2017, 12 (06):
[38] Robust in vivo gene editing in mouse hepatocytes with systemic lipid nanoparticle delivery of CRISPR/Cas9 components
Finn, J. D.
Patel, M.
Smith, A. Rhoden
Shaw, L.
Youniss, M.
Ciullo, C.
van Heteren, J.
Lescarbeau, R.
Seitzer, J.
Growe, J.
Dombrowski, C.
Strapps, W. R.
Barnes, T. M.
Morrissey, D. V.
HUMAN GENE THERAPY, 2016, 27 (11) : A131 - A131
[39] CRISPR/Cas9 mediated gene editing of Duchenne muscular dystrophy with a single gene deleted adenoviral vector
Ehrke-Schulz, E.
Mouly, V.
Ehrhardt, A.
HUMAN GENE THERAPY, 2019, 30 (11) : A161 - A161
[40] EFFICIENT GENOME EDITING OF MOUSE HEMATOPOIETIC CELLS USING CRISPR/CAS9 TECHNOLOGY
Sarrou, E.
Gibson, B.
Keeshan, K.
HAEMATOLOGICA, 2016, 101 : 295 - 295

← 1 2 3 4 5 →